CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Misses Revenue Estimates

EarningsNegative
AI Analysis

Summary

TScan Therapeutics reported Q2 results with a net loss and missed revenue estimates. The company's financial performance fell short of expectations.

Importance:2/10
Sentiment:
-0.50
earningsQ2revenue_missloss
Related Companies

Read the original article

Published by yahoo_finance on August 12, 2026 12:10 PM

Read Original